UK markets closed

Pharmagen, Inc. (PHRX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 03:36PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 465.37k
Enterprise value 5.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.08
Price/book (mrq)N/A
Enterprise value/revenue 1.35
Enterprise value/EBITDA -2.16

Trading information

Stock price history

Beta (5Y monthly) -0.42
52-week change 30.00%
S&P500 52-week change 326.27%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5517.08M
Implied shares outstanding 63.62B
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 245:1
Last split date 307 Dec 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2013
Most-recent quarter (mrq)31 Mar 2014

Profitability

Profit margin -133.10%
Operating margin (ttm)-31.11%

Management effectiveness

Return on assets (ttm)-58.91%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)4.41M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-23.30%
Gross profit (ttm)N/A
EBITDA -2.13M
Net income avi to common (ttm)-6.43M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)264.67k
Total cash per share (mrq)0
Total debt (mrq)3.39M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.10
Book value per share (mrq)-0.02

Cash flow statement

Operating cash flow (ttm)-483.09k
Levered free cash flow (ttm)4.41M